Filana Therapeutics Inc
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Biotechnology
業務概覽 Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
公司地址 6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
電話號碼 +1 512 501-2444
傳真號碼 +1 512 501-0414
公司網頁 https://www.cassavasciences.com
員工數量 30
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Jack Moore Senior Vice President, Clinical Development -- 21/04/2025
Mr. Richard J. Barry President, Chief Executive Officer and Director 美元 309.38K 14/04/2025
Mr. Remi Barbier Chairman of the Board, President and Chief Executive Officer 美元 1.19M 26/03/2024
Dr. Nadav Friedmann, M.D.,PhD Director and Chief Medical Officer 美元 365.00K 24/03/2022
Dr. James W. Kupiec, M.D. Chief Medical Officer 美元 449.00K 21/04/2025
Mr. R. Christopher Cook Chief Operating and Legal Officer -- 21/04/2025
Mr. Eric J. Schoen Chief Financial Officer and Principal Accounting Officer 美元 475.00K 21/04/2025
Ms. Freda Nassif Chief Business Officer -- 14/04/2025
 
董事會成員
董事會 職務 更新日期
Dr. Claude Nicaise,M.D. Chairman of the Board 14/04/2025
Mr. Richard J. Barry President, Chief Executive Officer and Director 14/04/2025
Dr. Patrick J. Scannon,M.D.,PhD Independent Director 14/04/2025
Mr. Remi Barbier Chairman of the Board, President and Chief Executive Officer 26/03/2024
Ms. Dawn Carter Bir Independent Director 22/10/2025
Dr. Nadav Friedmann, M.D.,PhD Director and Chief Medical Officer 24/03/2022
Mr. Sanford R. Robertson Lead Independent Director 26/03/2024
Mr. Pierre Gravier Independent Director 14/04/2025
Mr. Michael J. O'Donnell, Esq. Independent Director 14/04/2025
Dr. Robert Z. Gussin, PhD Independent Director 14/04/2025
Mr. Robert Anderson, Jr Independent Director 14/04/2025
 
所屬ETF (更新日期: 11/03/2026 07:30)
代號 名稱 佔比% ▼ 持有日期
OILTTexas Capital Texas Oil Index ETF<0.000001%26/12/2023
OMFSInvesco Russell 2000® Dynamic Mltfct ETF<0.000001%27/06/2022
ONEQFidelity Nasdaq Composite ETF<0.000001%21/03/2025
OPTZOptimize Strategy Index ETF<0.000001%24/03/2025
PBEInvesco Biotechnology & Genome ETF<0.000001%01/06/2023
PBEInvesco Dynamic Biotech & Genome ETF<0.000001%01/06/2023
PILLDirexion Daily Phrmctcl&MdclBl3XShrsETF<0.000001%23/12/2024
PSCPrincipal US Small Cap Mlt-Fac ETF<0.000001%02/05/2022
PTHInvesco DWA Healthcare Momentum ETF<0.000001%03/04/2023
PTHInvesco Dorsey Wright Healthcare MomtETF<0.000001%02/01/2025
RFLRInnovator U.S. Small Cp Mgd Flr ETF<0.000001%16/12/2024
RSSLGlobal X Russell 2000 ETF<0.000001%30/06/2025
RYLDGlobal X Russell 2000 Covered Call ETF<0.000001%27/06/2024
SBIOALPS Medical Breakthroughs ETF<0.000001%15/12/2023
SCHASchwab US Small-Cap ETF™<0.000001%23/09/2025
SCHBSchwab US Broad Market ETF™<0.000001%23/09/2025
SMMDiShares Russell 2500 ETF<0.000001%27/02/2026
SPGMSPDR® Portfolio MSCI Global Stk Mkt ETF<0.000001%03/03/2025
STXKStrive Small-Cap ETF<0.000001%25/01/2023
TILTFlexShares Mstar US Mkt Factors Tilt ETF<0.000001%23/12/2024
  1    2   3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.